Sanibel Captiva Trust Company’s GSK GSK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$597K Sell
10,809
-1,657
-13% -$89.8K 0.02% 286
2025
Q4
$611K Buy
12,466
+461
+4% +$21.5K 0.02% 273
2025
Q3
$518K Sell
12,005
-520
-4% -$20.3K 0.01% 289
2025
Q2
$481K Sell
12,525
-211
-2% -$8.06K 0.01% 285
2025
Q1
$493K Sell
12,736
-1,897
-13% -$69.4K 0.02% 273
2024
Q4
$495K Sell
14,633
-1,718
-11% -$61.8K 0.02% 277
2024
Q3
$668K Sell
16,351
-380
-2% -$15.5K 0.02% 249
2024
Q2
$644K Hold
16,731
0.02% 245
2024
Q1
$717K Buy
16,731
+90
+0.5% +$3.71K 0.02% 226
2023
Q4
$617K Buy
+16,641
New +$597K 0.02% 221

Other funds holding GSK

Sanibel Captiva Trust Company's GSK Position: Q1 2026 in Review

Sanibel Captiva Trust Company reduced its GSK (GSK) stake by 13% in Q1 2026, selling an estimated $89.8K and leaving 10,809 shares worth $597K. The position accounts for 0.02% of the portfolio, ranked #286.

Sanibel Captiva Trust Company first reported a position in GSK in Q4 2023 and has held it in 10 quarters since. The position peaked at $717K in Q1 2024. 1,032 funds tracked by Wall St. Rank hold GSK as of Q1 2026.

  • Sanibel Captiva Trust Company held 10,809 shares of GSK worth $597K as of Q1 2026.
  • Sanibel Captiva Trust Company sold 1,657 GSK shares in Q1 2026, an estimated $89.8K.
  • GSK made up 0.02% of Sanibel Captiva Trust Company's portfolio in Q1 2026, its #286 holding.
  • Sanibel Captiva Trust Company first reported a position in GSK in Q4 2023 and has held it in 10 quarters since.
  • Sanibel Captiva Trust Company's GSK position peaked at $717K in Q1 2024.
  • 1,032 funds tracked by Wall St. Rank held GSK as of Q1 2026.

Based on Sanibel Captiva Trust Company's 13F filing for Q1 2026, filed 15 May 2026.